Technology ID
TAB-4633

Real-Time RT-PCR Diagnostic Panel Assay for Universal Detection and Characterization of Asian Lineage Highly-Pathogenic Influenza Viruses A/H5 Subtype

E-Numbers
E-049-2017-0
Lead IC
CDC
Co-Inventors
Shu, Bo
Lindstrom, Stephen
Wu, Kai-Hui
Warnes, Christine
Berman, LaShondra
Liu, Ji
ICs
CDC
Applications
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
Research Products
Research Equipment

This technology includes an optimized influenza A/H5 subtyping real-time RT-PCR assay for detection and characterization of Asian lineage A/H5N1 viruses. The highly pathogenic avian influenza (HPAI) A/H5N1 viruses, first isolated in human in 1997, have spread among birds over seventy countries on three continents. In 2014 a novel reassortant HPAI A/H5N8 virus has been detected in poultry in Asia, Europe, As well as Canada and USA. In addition, genetic reassortment of this virus with circulating avian influenza viruses has resulted in the novel viral combinations. Due to the newly emerging novel reasserted A/H5Nx viruses detected in the USA, the assay, has been further updated and optimized by including extra primers and probe into the assay.

Commercial Applications
May be licensed to commercial entities to manufacture and sell commercial reagents to research and clinical laboratories.

Competitive Advantages
Assay allows for universal detection and characterization of Asian lineage highly pathogenic influenza viruses A/H5 subtype with high sensitivity and specificity.
Licensing Contact:
Motley, Jonathan
jonathan.motley@nih.gov